Crum-Cianflone Nancy F, Sullivan Eva
Internal Medicine Department, Scripps Mercy Hospital, San Diego, CA, USA.
Infectious Disease Division, Scripps Mercy Hospital, San Diego, CA, USA.
Infect Dis Ther. 2017 Sep;6(3):303-331. doi: 10.1007/s40121-017-0166-x. Epub 2017 Aug 4.
Vaccination is a critical component for ensuring the health of those living with the human immunodeficiency virus (HIV) by protection against vaccine-preventable diseases. Since HIV-infected persons may have reduced immune responses and shorter durations of protection post-vaccination, HIV-specific guidelines have been published by global and national advisory organizations to address these potential concerns. This article provides a comprehensive review of the current guidelines and evidence-based data for vaccinating HIV-infected adults, including guidance on modified vaccine dosing and testing strategies, as well as safety considerations, to enhance protection among this vulnerable population. In the current article, part I of the two-part series, inactivated vaccines with broad indications as well as vaccines for specific risk and age groups will be discussed.
接种疫苗是确保感染人类免疫缺陷病毒(HIV)者健康的关键组成部分,可预防疫苗可预防的疾病。由于HIV感染者接种疫苗后的免疫反应可能会降低,保护期也会缩短,全球和国家咨询组织已发布了针对HIV的特定指南,以解决这些潜在问题。本文全面综述了针对HIV感染成人接种疫苗的现行指南和循证数据,包括关于调整疫苗剂量和检测策略的指导以及安全考量,以加强这一弱势群体的保护。在这篇分为两部分的系列文章的第一部分中,将讨论具有广泛适应症的灭活疫苗以及针对特定风险和年龄组的疫苗。